Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-29

FDA Approved: CLENPIQ — Supplemental Application (Ferring Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application for CLENPIQ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) submitted by Ferring Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clenpiq (sodium picosulfate/magnesium citrate)

Snippet

SUPPL AP for CLENPIQ (SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID)